Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 in the release notes/footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the general government funding operating status notice from the page; the core trial content and data remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows minor UI/layout updates with no modification to core study information. Eligibility criteria, endpoints, and results remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T21:00:00.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a government funding status notice and NIH Clinical Center operating status guidance; updated version to v3.2.0 (removing v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T05:15:58.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Major update: new version v3.1.0 with expanded immune system terminology and related entities; old version v3.0.2 removed.
    Difference
    1%
    Check dated 2025-09-29T03:00:25.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Version updated to v3.0.2 and the Back to Top link was removed; no substantive content changes were observed.
    Difference
    0.2%
    Check dated 2025-09-14T19:00:03.000Z thumbnail image

Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.